In accordance with Article 63(1) of Regulation (EU) No 536/2014 of the European Parliament and of the Council [Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (OJ L 158, 27.5.2014, p. 1).] the Commission is empowered to adopt a delegated act laying down principles of good manufacturing practice for investigational medicinal products for human use. It is therefore necessary to adapt the provisions of Directive 2003/94/EC by deleting the references to investigational medicinal products for human use.
Recital 2, Directive (EU) 2017/1572
In forcesince 15 Sep 2017